References
- Liden Y, Landgren O, Arner S, . Procedure-related pain among adult patients with hematologic malignancies. Acta Anaesthesiol Scand 2009;53:354–363.
- Degen C, Christen S, Rovo A, . Bone marrow examination: a prospective survey on factors associated with pain. Ann Hematol 2010;89:619–624.
- Campbell JK, Matthews JP, Seymour JF, . Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003;14:273–276.
- Wang J, Weiss LM, Chang KL, . Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 2002;94:1522–1531.
- Brunning RD, Bloomfield CD, McKenna RW, . Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975;82:365–366.
- Redman HC, Glatstein E, Castellino RA, . Computed tomography as an adjunct in the staging of Hodgkin's disease and non-Hodgkin's lymphomas. Radiology 1977;124:381–385.
- Front D, Bar-Shalom R, Epelbaum R, . Early detection of lymphoma recurrence with gallium-67 scintigraphy. J Nucl Med 1993;34:2101–2104.
- Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med 1987;28:288–292.
- Wahl RL, Kaminski MS, Ethier SP, . The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med 1990;31:1831–1835.
- Pakos EE, Fotopoulos AD, Ioannidis JP. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 2005;46:958–963.
- Muslimani AA, Farag HL, Francis S, . The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. Am J Clin Oncol 2008;31:409–412.
- Hutchings M, Loft A, Hansen M, . Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006;91:482–489.
- Elstrom RL, Leonard JP, Coleman M, . Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 2008;19:1770–1773.
- Richardson SE, Sudak J, Warbey V, . Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era. Leuk Lymphoma 2012;53:381–385.
- Zhang QY, Foucar K. Bone marrow involvement by Hodgkin and non-Hodgkin lymphomas. Hematol Oncol Clin North Am 2009;23:873–902.
- Purz S, Mauz-Korholz C, Korholz D, . [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. J Clin Oncol 2011;29:3523–3528.
- Cerci JJ, Trindade E, Buccheri V, . Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. Clin Lymphoma Myeloma Leuk 2011;11:314–320.
- Moulin-Romsee G, Hindie E, Cuenca X, . (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010;37:1095–1105.
- Cheng G, Chen W, Chamroonrat W, . Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 2011;38: 1469–1476.
- Carr R, Barrington SF, Madan B, . Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998;91:3340–3346.
- Hofman MS, Smeeton NC, Rankin SC, . Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging. J Nucl Med 2009;50:1594–1597.
- Sehn LH, Scott DW, Chhanabhai M, . Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2011;29: 1452–1457.
- Hofman MS, Hicks RJ. Imaging in follicular NHL. Best Pract Res Clin Haematol 2011;24:165–177.